INTECH Investment Management’s Pacira BioSciences PCRX Stock Holding History

INTECH Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.05M	Buy	41,291 +10,230	+33%	+$242K	0.01%	1007
2026 Q1	$702K	Sell	31,061 -135,654	-81%	-$3.01M	0.01%	1176
2025 Q4	$4.31M	Buy	166,715 +103,593	+164%	+$2.46M	0.04%	426
2025 Q3	$1.63M	Buy	63,122 +41,137	+187%	+$1.01M	0.01%	890
2025 Q2	$525K	Hold	21,985	–	–	﹤0.01%	1586
2025 Q1	$546K	Buy	21,985 +5,018	+30%	+$120K	0.01%	1561
2024 Q4	$320K	Buy	16,967 +4,251	+33%	+$74.6K	﹤0.01%	1808
2024 Q3	$191K	Buy	+12,716	New	+$217K	﹤0.01%	1743

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

INTECH Investment Management's PCRX Position: Q2 2026 in Review

INTECH Investment Management increased its Pacira BioSciences (PCRX) stake by 33% in Q2 2026, buying an estimated $242K and bringing the position to 41,291 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #1007.

INTECH Investment Management first reported a position in PCRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.31M in Q4 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

INTECH Investment Management held 41,291 shares of Pacira BioSciences worth $1.05M as of Q2 2026.
INTECH Investment Management bought 10,230 Pacira BioSciences shares in Q2 2026, an estimated $242K.
Pacira BioSciences made up 0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1007 holding.
INTECH Investment Management first reported a position in Pacira BioSciences in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Pacira BioSciences position peaked at $4.31M in Q4 2025.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.